Physician

Thomas Jay Tsai, MD

According to 2025 Medicare claims, Thomas Tsai, MD (NPI: 1316919640) practices ophthalmology in the Akron, OH market, with the plurality of this provider's patient population coming from Summit, OH. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF CLEVELAND, INC. (NPI: 1912991225; TIN: 34-1411937) and primary practice location at 44223-2105. Tsai is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Tsai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 26,747 HCPCS/CPT codes, and received $2,720,352 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 351 prescription claims across 164 beneficiaries totaling $21,362 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 38 records totaling $1,005. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $22,244 and ending at $21,362. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	709	8,168	$1,708,362
2016	864	8,630	$2,070,272
2017	911	9,625	$2,312,869
2018	876	10,034	$2,157,280
2019	770	8,344	$2,110,563
2020	660	7,984	$2,109,387
2021	668	7,945	$2,083,237
2022	683	12,641	$1,941,827
2023	656	28,045	$2,103,646
2024	700	26,747	$2,720,352

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	90	223	$22,244
2016	79	172	$16,899
2017	79	201	$17,708
2018	93	225	$20,396
2019	78	180	$10,857
2020	76	148	$10,932
2021	109	233	$16,260
2022	121	261	$26,073
2023	132	278	$21,184
2024	164	351	$21,362

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0177	Injection, aflibercept hd, 1 mg	153	4,240	$264
67028	Injection of drug into eye	275	1,033	$89
92012	Established patient problem focused exam of visual system	365	837	$57
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	216	$56
92134	Imaging of retina	612	1,638	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	108	3,778	$3,863
Alphagan P	Brimonidine Tartrate	12	422	$3,613
Bromfenac Sodium	Bromfenac Sodium	23	641	$2,996
Brimonidine Tartrate	Brimonidine Tartrate	12	474	$891
Ofloxacin	Ofloxacin	84	2,098	$874

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$1,005	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Jay Tsai, MD?

Tedicare shows public-source Medicare data for Thomas Jay Tsai, MD (NPI 1316919640), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Jay Tsai, MD have ACO affiliation data?

Thomas Jay Tsai, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Thomas Jay Tsai, MD?

Thomas Jay Tsai, MD is linked to RETINA ASSOCIATES OF CLEVELAND, INC. (billing NPI 1912991225) in the available physician profile data.

Does Thomas Jay Tsai, MD have Open Payments data?

Thomas Jay Tsai, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.